Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,009.50    -16.50 (-1.61%)
Bid:
1,014.50
Ask:
1,015.50
Spread: 1.00 (0.099%)
Market Cap: £4.97b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Final Terms

10 Jul 2026 17:35

RNS Number : 9659L
Babcock International Group PLC
10 July 2026
 

 

 

10 July 2026

Babcock International Group PLC

 

BABCOCK INTERNATIONAL GROUP PLC £250 million BOND ISSUE

Babcock International Group ('the Group' or 'Babcock') announces the issue of £250 million of five-year bonds carrying fixed coupon of 5.125%, the Group's first bond issue for seven years, to refinance the £300 million bond maturing in October 2026.

 

Babcock's strong proposition, fundamentals and balance sheet, combined with leading market positioning in defence and nuclear, has led to a high level of demand, allowing us to price on attractive terms.

 

The net proceeds of the issue will be used for general corporate purposes, including ongoing investment to support and drive growth.

 

BABCOCK ANNOUNCES PUBLICATION OF FINAL TERMS

The final terms dated 10 July 2026 (the "Final Terms") relating to the issue by Babcock on 14 July 2026 of GBP 250,000,000 5.125% per cent notes due 2026 (the "Notes") have been submitted to the UK Listing Authority and are available for viewing.

The Notes have been issued pursuant to the base prospectus dated 3 March 2026 (the "Base Prospectus") relating to the £3,000,000,000 Euro Medium Term Note Programme (the "Programme") of Babcock.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/9659L_1-2026-7-10.pdf

A copy of the Final Terms has been submitted to the National Storage Mechanism and will be available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information please contact:

 

Andrew Gollan

Samuel MacGregor

Director of Investor Relations

Investor Relations Manager

Tel: (0)7936 039004

Tel: (0)7730 753159

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain whether or not you are part of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. This is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States and securities in bearer form are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered, sold or (in the case of securities in bearer form) delivered within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTRMMFTMTJBBBF
Date   Source Headline
27th Mar 20177:22 amRNSMagnox decommissioning contract
24th Mar 20179:54 amRNSHolding(s) in Company
14th Mar 20177:00 amRNSRealignment Presentation
28th Feb 20177:00 amRNSTrading Update
24th Feb 20171:00 pmRNSHolding(s) in Company
15th Feb 201712:11 pmRNSHolding(s) in Company
9th Feb 20174:53 pmRNSHolding(s) in Company
7th Feb 20175:00 pmRNSDirector Declaration
3rd Feb 20175:23 pmRNSHolding(s) in Company
20th Jan 201710:01 amRNSDirector/PDMR Shareholding
5th Jan 20179:00 amRNSFOMEDEC Contract Award
12th Dec 20161:19 pmRNSDirector Declaration
28th Nov 20164:18 pmRNSHolding(s) in Company
28th Nov 201611:07 amRNSDirector/PDMR Shareholding
23rd Nov 20163:48 pmRNSHolding(s) in Company
23rd Nov 20162:56 pmRNSHolding(s) in Company
22nd Nov 20167:00 amRNSHalf-year Report
21st Nov 201611:13 amRNSContract Award
21st Oct 20164:11 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSCapital Markets Day site visit
13th Oct 20161:14 pmRNSContract Award
4th Oct 201612:46 pmRNSPublication of Final Terms
23rd Sep 20164:45 pmRNSHolding(s) in Company
20th Sep 201611:37 amRNSPublication of a Prospectus
16th Sep 201612:39 pmRNSHolding(s) in Company
8th Sep 20169:00 amRNSContract Award
16th Aug 20164:44 pmRNSDirector/PDMR Shareholding
29th Jul 20164:30 pmRNSDirector/PDMR Shareholding
21st Jul 20164:32 pmRNSResult of AGM
21st Jul 20167:00 amRNSAnnual General Meeting Trading Update
20th Jul 20163:45 pmRNSHolding(s) in Company
8th Jul 20169:31 amRNSHolding(s) in Company
28th Jun 20169:13 amRNSDirector/PDMR Shareholding
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
20th Jun 20163:17 pmRNSDirector/PDMR Shareholding
17th Jun 201610:22 amRNSDirector/PDMR Shareholding
16th Jun 20163:44 pmRNSDirector/PDMR Shareholding
16th Jun 20169:14 amRNSAnnual Report and AGM Documents
14th Jun 20163:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20161:56 pmRNSTotal Voting Rights
31st May 20163:29 pmRNSAdditional Listing
25th May 20167:00 amRNSFinal Results
20th May 20168:00 amRNSContract Announcement
18th May 20164:10 pmRNSHolding(s) in Company
12th May 20162:05 pmRNSDirector/PDMR Shareholding
12th May 20162:04 pmRNSDirector/PDMR Shareholding
13th Apr 20164:32 pmRNSDirector/PDMR Shareholding
13th Apr 20164:29 pmRNSDirector/PDMR Shareholding
14th Mar 20162:14 pmRNSDirector/PDMR Shareholding
14th Mar 201610:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.